Lentechs, a U.S. clinical-stage ophthalmic device company focusing on innovative contact lens technology, has completed a $6 million fundraise from Vision Vestments and other financial investors. Lentechs said the funds would be allocated to achieve key clinical research and manufacturing development objectives for APIOC, its line of contact lenses specifically ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.